Why does consciousness exist? This question lies at the heart of my book, A Philosophy for the Science of Animal ...
Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis IND application for Descartes-08 in myositis accepted by FDA; ...
IND application for Descartes-08 in myositis accepted by FDA; seamless adaptive clinical trial offering potential opportunity for a single pivotal trial expected to commence in 1H26 Phase 1/2 ...
Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis IND application for Descartes-08 in myositis accepted by FDA; seamless adaptive clinical trial offering potential ...
Factorial’s high-power, lightweight, solid-state batteries have demonstrated real-world performance, including over 1,200 km (745 miles) of driving range in vehicle testing and are being advanced ...
The Brighterside of News on MSN
Runaway stars within the Milky Way may reveal dark matter’s hidden structure
Astronomers have chased hypervelocity stars for more than a century. These rare objects move so fast that the Milky Way ...
Cartesian Growth II ( (RENEF)) just unveiled an announcement. On December 29, 2025, Cartesian Growth Corporation II issued a $200,000 unsecured, non-interest-bearing promissory note to its sponsor, ...
Cartesian Therapeutics is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T in Phase 3 clinical development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback